HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Combination therapy of cyclophosphamide and Rhizoma Paridis Saponins on anti-hepatocarcinoma mice and effects on cytochrome p450 enzyme expression.

Abstract
Rhizoma Paridis Saponins (RPS), which is the effective part of Rhizoma Paridis, showed strong activity against lung cancer and hepatocarcinoma. In this research, a combination of RPS with cyclophosphamide (CTX) was used to treat hepatocarcinoma in mice. Although no active enhancement of activity was observed, some attenuation of the toxicity of RPS in combination with CTX occurred. In order to explain this phenomenon, we carried out research on the effects of Rhizoma Paridis Saponins on the activities of cytochrome p450 enzymes CYP1A2, CYP2A6, CYP2B6, CYP2C9, CYP2E1 and CYP3A4. The results indicated that RPS significantly influenced the activity of CYP2B6 and CYP3A4 through the inhibition of protein expression. However, RPS did not affect the activity of CYP1A2, CYP2A6, CYP2C9 and CYP2E1 in rats in vivo. These results suggested that RPS inhibited the conversion of cyclophosphamide into active metabolites and inactive byproducts through the reduced activities of CYP2B6 and CYP3A4. Therefore, it's essential to pay attention to CYP2B6- and CYP3A4-mediated herb-drug interactions between RPS and other drugs.
AuthorsShuli Man, Yuanyuan Li, Wei Fan, Wenyuan Gao, Zhen Liu, Yao Zhang, Changxiao Liu
JournalSteroids (Steroids) Vol. 80 Pg. 1-6 (Feb 2014) ISSN: 1878-5867 [Electronic] United States
PMID24291418 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
CopyrightCopyright © 2013 Elsevier Ltd. All rights reserved.
Chemical References
  • Antineoplastic Agents
  • Cytochrome P-450 Enzyme Inhibitors
  • Saponins
  • Cyclophosphamide
  • Cytochrome P-450 Enzyme System
Topics
  • Animals
  • Antineoplastic Agents (administration & dosage, blood, pharmacology)
  • Carcinoma, Hepatocellular (drug therapy, pathology)
  • Cell Proliferation (drug effects)
  • Cyclophosphamide (administration & dosage, blood, pharmacology)
  • Cytochrome P-450 Enzyme Inhibitors (pharmacology)
  • Cytochrome P-450 Enzyme System (biosynthesis, metabolism)
  • Dose-Response Relationship, Drug
  • Female
  • Liver Neoplasms (drug therapy, pathology)
  • Mice
  • Mice, Inbred Strains
  • Neoplasms, Experimental (drug therapy, pathology)
  • Rats
  • Rats, Sprague-Dawley
  • Rhizome (chemistry)
  • Saponins (administration & dosage, blood, pharmacology)
  • Structure-Activity Relationship
  • Xenograft Model Antitumor Assays

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: